In This Issue
National Clinical Effectiveness Committee - Submission of Clinical Guidelines
Think ahead: How it can help healthcare professionals and their patients
IMB - Information for patients on safety monitoring of medicines
Events, Courses and Research that may be of interest to you
Useful Links
About us »
Feedback »
Visit our website »
Upcoming events »
Newsletter section »
Education courses »
Contact us »
Contact

Ph: 01 639 8500

Fax: 01 639 8595

Email: ezine@nmbi.ie

Web: www.nmbi.ie


National Clinical Effectiveness Committee - Submission of Clinical Guidelines
Clinical guidelines are systematically developed statements, based on a thorough evaluation of the evidence, to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances, across the entire clinical spectrum.



In order to ensure that the national suite of clinical guidelines address health care priorities and are based on the highest level of evidence the NCEC will prioritise, appraise and make recommendations to the Minister for Health to endorse clinical guidelines. It is recognised that the NCEC, and the health system as a whole, is likely to be able to effectively implement and monitor only a small number of new national clinical guidelines each year.  Not all clinical guidelines need to be submitted for national endorsement and guideline development groups should continue to develop clinical guidelines in response to the needs of their own organisations.  However, once a national clinical guideline is endorsed it will supersede any other guidelines on that topic.


The deadline for submission of clinical guidelines for consideration by NCEC is 5pm, March 5th, 2013.



In order for clinical guidelines to be endorsed at national level they must meet certain criteria as outlined in the 8 step process in the Framework for Endorsement of National Clinical Guidelines (2012).  All guideline submissions must include the Checklist for Submission to NCEC.



The following may also be helpful to clinical guideline development groups:


NCEC Framework for Endorsement of National Clinical Guidelines, Version 2 (2012)


NCEC Clinical Guideline Development Manual (2012)


NCEC Clinical Guideline Screening and Prioritisation Criteria Version 3 (2012)


HIQA National Quality Assurance Criteria for Clinical Guidelines (2011)


Complete the Agree II Tutorial - www.agreetrust.org


All NCEC documentation on how to submit are available at http://www.patientsafetyfirst.ie


All HIQA documentation is available at www.hiqa.ie


Notice of Intent to Develop a Clinical Guideline: Guideline development groups are encouraged to notify their intent to develop a clinical guideline or that they have a guideline currently in development which they intend to submit to the NCEC.   


The main purpose of this is to share information with all stakeholders who have an interest in a clinical area, in order to allow them communicate with each other and to prevent the possible duplication of effort where a number of stakeholders are undertaking work in the same area.   


This notification neither commits the guideline development group to submit their guideline to NCEC, nor does it indicate that the guideline will be endorsed by NCEC. The list of guideline development groups who notify their intent to develop clinical guidelines which they intend to submit to the NCEC will be published on the NCEC website.


For further information or queries regarding submission of clinical guidelines please contact:


Antoinette Treacy

Department of Health

Hawkins House

Dublin 2

Email: ncec@health.gov.ie

Telephone: 01 6354115

www.patientsafetyfirst.ie



Rate: 12345 (0) | Share
Newsletter Marketing Powered by Newsweaver